Literature DB >> 6165019

Production of hybridomas secreting monoclonal antibodies to the human leukocyte interferons.

T Staehelin, B Durrer, J Schmidt, B Takacs, J Stocker, V Miggiano, C Stähli, M Rubinstein, W P Levy, R Hershberg, S Pestka.   

Abstract

Thirteen monoclonal antibodies to human leukocyte interferon have been obtained. They exhibit different patterns of binding to purified leukocyte interferon species that are consistent with the structural multiplicity of the human leukocyte interferons. These antibodies will be useful as probes into the structure of the human leukocyte interferons, for their purification, and for rapid assay of leukocyte interferon.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6165019      PMCID： PMC319232          DOI： 10.1073/pnas.78.3.1848

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


  13 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity.

Authors:  H P Koeffler; D W Golde
Journal:  Science       Date:  1978-06-09       Impact factor: 47.728

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  High frequencies of antigen-specific hybridomas: dependence on immunization parameters and prediction by spleen cell analysis.

Authors:  C Stähli; T Staehelin; V Miggiano; J Schmidt; P Häring
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

5.  A monoclonal antibody for large-scale purification of human leukocyte interferon.

Authors:  D S Secher; D C Burke
Journal:  Nature       Date:  1980-06-12       Impact factor: 49.962

6.  The nucleotide sequence of a cloned human leukocyte interferon cDNA.

Authors:  N Mantei; M Schwarzstein; M Streuli; S Panem; S Nagata; C Weissmann
Journal:  Gene       Date:  1980-06       Impact factor: 3.688

7.  Construction and identification of bacterial plasmids containing nucleotide sequence for human leukocyte interferon.

Authors:  S Maeda; R McCandliss; M Gross; A Sloma; P C Familletti; J M Tabor; M Evinger; W P Levy; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

8.  Human leukocyte interferon: production, purification to homogeneity, and initial characterization.

Authors:  M Rubinstein; S Rubinstein; P C Familletti; R S Miller; A A Waldman; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

9.  Solid-phase radioimmunoassay in antibody-coated tubes.

Authors:  K Catt; G W Tregear
Journal:  Science       Date:  1967-12-22       Impact factor: 47.728

10.  Human leukocyte interferon purified to homogeneity.

Authors:  M Rubinstein; S Rubinstein; P C Familletti; M S Gross; R S Miller; A A Waldman; S Pestka
Journal:  Science       Date:  1978-12-22       Impact factor: 47.728
View more
  10 in total

1.  Production and purification of monoclonal antibodies to Pisum and Avena phytochrome.

Authors:  M M Cordonnier; C Smith; H Greppin; L H Pratt
Journal:  Planta       Date:  1983-08       Impact factor: 4.116

2.  Production of high levels of human leukocyte interferon from a continuous human myeloblast cell culture.

Authors:  P C Familletti; R McCandliss; S Pestka
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

3.  Evolution of recurrent herpes simplex lesions. An immunohistologic study.

Authors:  A L Cunningham; R R Turner; A C Miller; M F Para; T C Merigan
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

Review 4.  Electric field-induced cell-to-cell fusion.

Authors:  U Zimmermann; J Vienken
Journal:  J Membr Biol       Date:  1982       Impact factor: 1.843

5.  The nature of neutralization reaction between effector protein and monoclonal antibody: a quantitative study of neutralization characteristics of anti-interferon antibodies.

Authors:  Y Kawade; Y Watanabe
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

6.  Development and use of enzyme-linked immunosorbent assays (ELISA) for the detection of protein aggregates in interferon-alpha (IFN-alpha) formulations.

Authors:  A Braun; J Alsenz
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

7.  Monoclonal antibodies against murine gamma interferon.

Authors:  M Prat; G Gribaudo; P M Comoglio; G Cavallo; S Landolfo
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

8.  Safety and tolerance of recombinant leukocyte A interferon in bone marrow transplant recipients.

Authors:  D J Winston; W G Ho; R W Schroff; R E Champlin; R P Gale
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

9.  Orientation of a human leukocyte interferon molecule on its cell surface receptor: carboxyl terminus remains accessible to a monoclonal antibody made against a synthetic interferon fragment.

Authors:  H Arnheiter; M Ohno; M Smith; B Gutte; K C Zoon
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

10.  Normal human epidermis contains an interferon-like protein.

Authors:  M Yaar; A V Palleroni; B A Gilchrest
Journal:  J Cell Biol       Date:  1986-10       Impact factor: 10.539
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.